AIGH Capital Management’s TELA Bio TELA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,416,323
Closed -$1.73M 43
2025
Q1
$1.73M Sell
1,416,323
-1,246,462
-47% -$3.06M 0.72% 31
2024
Q4
$8.04M Buy
2,662,785
+193,412
+8% +$544K 2.51% 17
2024
Q3
$6.25M Buy
2,469,373
+812,718
+49% +$2.89M 1.76% 14
2024
Q2
$7.79M Buy
1,656,655
+241,400
+17% +$1.27M 2.43% 11
2024
Q1
$8.02M Buy
1,415,255
+37,310
+3% +$246K 2.41% 9
2023
Q4
$9.12M Buy
1,377,945
+125,000
+10% +$722K 3.61% 9
2023
Q3
$10M Sell
1,252,945
-405,000
-24% -$3.76M 4.74% 6
2023
Q2
$16.8M Buy
1,657,945
+4,326
+0.3% +$44.2K 6.85% 5
2023
Q1
$17.6M Sell
1,653,619
-25,662
-2% -$283K 6.49% 4
2022
Q4
$19.3M Buy
1,679,281
+149,612
+10% +$1.34M 6.36% 4
2022
Q3
$13M Buy
1,529,669
+1,223,205
+399% +$10.1M 4.05% 8
2022
Q2
$2.16M Buy
+306,464
New +$2.54M 0.57% 28

Other funds holding TELA

AIGH Capital Management's TELA Position: Q2 2025 in Review

AIGH Capital Management sold out of TELA Bio (TELA) in Q2 2025, closing a stake of 1,416,323 shares — an estimated $1.73M sold.

AIGH Capital Management first reported a position in TELA in Q2 2022 and held it in 12 quarters. The position peaked at $19.3M in Q4 2022. 46 funds tracked by Wall St. Rank hold TELA as of Q2 2025.

  • AIGH Capital Management reported no remaining TELA Bio position as of Q2 2025 after selling out during the quarter.
  • AIGH Capital Management sold 1,416,323 TELA Bio shares in Q2 2025, an estimated $1.73M.
  • AIGH Capital Management first reported a position in TELA Bio in Q2 2022 and held it in 12 quarters.
  • AIGH Capital Management's TELA Bio position peaked at $19.3M in Q4 2022.
  • 46 funds tracked by Wall St. Rank held TELA Bio as of Q2 2025.

Based on AIGH Capital Management's 13F filing for Q2 2025, filed 29 Jul 2025.